Neuronetics Announces Expanded TRICARE Coverage for NeuroStar TMS in Adolescents Aged 15+

Neuronetics, a medical technology company, announced that TriWest, the regional administrator for TRICARE, has updated its medical policy to include TMS coverage for adolescents aged 15 and older. This decision expands access to the NeuroStar Advanced Therapy for younger patients struggling with depression. Neuronetics welcomes this step forward in providing innovative, evidence-based care to those who need it most and remains committed to working with providers and policymakers to expand adolescent access to TMS nationwide.